Clinical Trial

Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy

Name: Clinical Biomarker of Paclitaxel-induced Peripheral Neuropathy — clinical trial record (NCT06430814)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

Investigation of which patients treated with paclitaxel have an increased risk of developing peripheral neuropathy.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-05-23; most recent amendment 2025-08-25.

Status change: Not Yet Recruiting → Recruiting 2025-02-24

Trial Details

NCT Number	NCT06430814
Lead Sponsor	University of Southern Denmark Collaborators: Odense University Hospital, Sygehus Lillebaelt, Sonderborg Hospital
Conditions	Chemotherapy-induced Peripheral Neuropathy
Enrollment	188 participants
Start Date	2024-10-10
Primary Completion	2027-09 (estimated)
Study Completion	2027-09 (estimated)
Updated on ClinicalTrials.gov	2025-09-02